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Abstract
Introduction Inguinal hernia operations in the presence of
antithrombotic therapy, based on antiplatelet or anticoag-
ulant drugs, or existing coagulopathy are associated with a
markedly higher risk for onset of postoperative secondary
bleeding. To date, there is a paucity of concrete data on this
important clinical aspect of inguinal hernia surgery. Up till
now, the endoscopic (TEP, TAPP) techniques have been
considered to be more risky because of the extensive dis-
section involved.
Patients and methods Out of the 82,911 patients featured
in the Herniamed Hernia Registry who had undergone
inguinal hernia repair, 9115 (11 %) were operated on while
receiving antithrombotic therapy or with existing coagu-
lopathy. The implications of that risk profile for onset of
postoperative bleeding were investigated in multivariable
analysis. In addition, other influence variables were
identified.
Results The rate of postoperative secondary bleeding, at
3.91 %, was significantly higher in the risk group with
coagulopathy or receiving antithrombotic therapy than in
the group without that risk profile at 1.12 % (p\ 0.001).
Multivariable analysis revealed other influence variables
which, in addition to coagulopathy or antithrombotic
therapy, had a relevant influence on the occurrence of
postoperative bleeding. These were open operation, a
higher age, a higher ASA score, recurrence, male gender
and a large hernia defect.
Summary Patients receiving antithrombotic therapy or
with existing coagulopathy who undergo inguinal hernia
operation have a fourfold higher risk for onset of postop-
erative secondary bleeding. Despite the extensive dissec-
tion required for endoscopic (TEP, TAPP) inguinal hernia
repair, the risk of bleeding complications and complica-
tion-related reoperation appears to be lower.
Keywords Inguinal hernia repair  TEP  TAPP 
Bleeding complication  Antithrombotic therapy 
Coagulopathy
Against a background of a progressively aging population,
candidates for inguinal hernia repair are often elderly and
have comorbidities. Therefore, it is not uncommon for the
patients to be on antiplatelet or anticoagulant therapy [1].
Because antithrombotic agents are associated with longer
bleeding time, the risk of postoperative hemorrhage is
increased [1]. Prophylactic or therapeutic use of anticoag-
ulants and platelet aggregation inhibitors confronts the
treating surgeon with the challenge of protecting patients
against thromboembolic complications without inducing
bleeding complications. That calls for careful perioperative
risk/benefit assessment with regard to the use of such
therapeutics [2]. If it is possible to suspend platelet
aggregation inhibitors for seven days or discontinue oral
anticoagulant therapy and effect bridging with heparin,
inguinal hernia surgery can be performed without increased
risk of postoperative bleeding [3, 4]. But if, based on
multidisciplinary consensus, antithrombotic medication
cannot be dispensed with, a higher risk of bleeding
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complications must be countenanced. To date, there is a
paucity of data on the risk associated with conduct of
inguinal hernia operation in patients on antithrombotic
therapy [5]. In addition to those patients receiving
antithrombotic drug therapy, patients with coagulopathies,
e.g., in the presence of cirrhosis of the liver, constitute a
subgroup of individuals with a markedly higher risk profile
for bleeding complications. The rate of bleeding compli-
cations secondary to inguinal hernia operations is given in
the literature as being up to 7.9 % [6, 7]. In the Swedish
Inguinal Hernia Registry, postoperative hematomas
occurred in 3.5 % of 150,514 inguinal hernia operations
[8]. Since endoscopic (TEP, TAPP) inguinal hernia repair
needs extensive dissection at the preperitoneal space to
place the mesh over the inguinal floor, there may be a
higher risk of postoperative hemorrhage or hematoma
compared with open repair [1].
Based on data from the Herniamed Registry [9], this
present analysis now attempts to ascertain the rate of
postoperative bleeding complications following inguinal
hernia operations among patients with coagulopathy or
receiving antiplatelet and anticoagulant therapy compared
with that of patients who did not have a higher risk. Fur-
thermore, it aims to identify other influence factors for the
occurrence of bleeding complications in relation to ingu-
inal hernia repair. It also endeavors to identify whether the
risk of postoperative bleeding complications is really
higher in the risk group with coagulopathy, anticoagulant
or antiplatelet therapy following endoscopic (TEP, TAPP)
repair compared with open operation.
Patients and methods
Herniamed is a multicenter, internet-based Hernia Reg-
istry in which 383 participating clinics and surgeons in
private practice from Germany, Austria and Switzerland
(status: March 5, 2014) have prospectively registered their
patients who had undergone hernia operation [9]. This
present analysis now compares the prospective data of all
patients who had undergone either unilateral or bilateral
repair of an inguinal hernia between September 1, 2009,
and March 5, 2014. Other inclusion criteria were a min-
imum age of 16 years, elective surgery and primary or
recurrent operation. In total, 82,911 patients were enrol-
led. These comprised 69,508 patients with unilateral and
13,403 patients with bilateral inguinal repair. An open
operation method was used in 35,370 of cases (Lichten-
stein n = 22,926, Plug n = 3571, Shouldice n = 2919,
Gilbert n = 2544, TIPP n = 1648, others n = 1762) and
an endoscopic/laparoscopic technique in 47,541 cases
(TAPP n = 29,292, TEP n = 18,249). The patient group
at increased risk for onset of postoperative bleeding
complications was defined as that comprising patients
with either existing coagulopathy (e.g., in the presence of
liver cirrhosis), currently receiving platelet aggregation
inhibitor therapy or who had discontinued such therapy
less than 7 days prior to the operation or patients whose
Quick or INR value was not within the normal range
during the operation due to treatment with coumarin.
Since in a registry setting any increased risk for onset of
postoperative bleeding complications can only be identi-
fied following inguinal hernia operation, no additional
details, such as the product names of the platelet aggre-
gation inhibitors, exact number of days they had been
discontinued or the exact INR value, were recorded.
Other potential influence factors investigated were the
surgical technique (endoscopic/open), age, sex, ASA sta-
tus, hernia defect size based on EHS classification (grades
I–III) and primary operation versus recurrence.
The outcome variable defined was postoperative sec-
ondary bleeding within 30 days of the operation. Postop-
erative secondary bleeding is defined as large surface
bleeding into the skin surrounding the operation area and
into the scrotum, hematomas in the operation area, major
blood loss from indwelling drains and reoperations because
of secondary bleeding. On one-year follow-up, patients are
clearly asked again about the occurrence of such bleeding
complications. In the case of bilateral inguinal hernias,
postoperative secondary bleeding was deemed to have
occurred if there was secondary bleeding on at least one of
the two sides.
Unadjusted analysis was carried out to analyze an
individual influence variable in respect of a target param-
eter. The main focus here was on the influence exerted by
coagulopathy or antithrombotic therapy on increased
bleeding risk. Fisher’s exact test was used for a categorical
outcome variable, in particular since often individual
number values were relatively small. However, it was not
possible to use Fisher’s exact test for contingency tables of
a higher dimension than 2 9 2 due to the large patient
number. The asymptotic Chi-square test was used instead.
The robust t test was used for continuous outcome vari-
ables that followed the normal distribution (Satterthwaite)
to analyze the influence exerted by coagulopathy or
antithrombotic therapy.
A binary logistic regression model was used to study the
influence of patient (demographic) and surgery-related
characteristics as well as of an increased bleeding risk
associated with existing coagulopathy or antithrombotic
therapy on the postoperative secondary bleeding rate, while
the odds ratio with 95 % confidence interval was based on
the Wald test. For influence variables with more than two
categories, one of the latter forms was used in each case as
reference category. For the continuous influence variable
‘age,’ the 10-year odds ratio is given.
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Results
Out of all patients who had undergone inguinal hernia
operation, n = 9115/82,911 (11 %) had either existing
coagulopathy or were still receiving effective antiplatelet
or anticoagulant therapy. Out of these 9115 patients,
n = 1207 (13.24 %) patients had coagulopathy, n = 1941
(21.29 %) a Quick or INR value that following coumarin
therapy was outside the normal range, and n = 6641
(72.86 %) of patients had received treatment with platelet
aggregation inhibitors which had been discontinued less
than 7 days previously or had not at all been discontinued.
As such, 33 out of 9115 patients had all three of these risk
factors, 181 patients had received both coumarin deriva-
tives and platelet aggregation inhibitors, 186 patients had
existing coagulopathy in addition to receiving treatment
with coumarin derivatives, and 241 patients had, in addi-
tion to existing coagulopathy, been treated with platelet
aggregation inhibitors.
Unadjusted analysis
Unadjusted analysis of the relationship of the risk group
(coagulopathy, anticoagulant or antiplatelet therapy) and
the non-risk group with the variables patient- and surgery-
specific characteristics showed that there were highly
significant differences between the risk group and the
non-risk group with regard to all variables (in each case
p\ 0.001) (Table 1). For example, more open operations
had been performed in the risk group (55.95 vs. 41.02 %).
Besides, the proportion of male patients in the risk group
was significantly greater (91.27 vs. 88.23 %). Likewise,
there were significant differences in ASA classifications
in that respect. In the risk group, the proportion of
patients in ASA I was only 2.74 %, while in the non-risk
group, it was 37.74 %. There were also significantly
fewer cases of a small hernia defect (EHS I) in the risk
group, at 10.61 %, compared with the non-risk group at
17.51 %. The proportion of recurrences in the risk group
at 12.18 % was significantly higher than in the non-risk
group at 10.55 % (Table 1). Furthermore, the proportion
of bilateral operations in the risk group, at 12.59 %, was
significantly lower than in the non-risk group, at 16.56 %
(p\ 0.001). Conversely, the use of drains in the risk
group, at 37.03 %, was significantly higher than in the
non-risk group, at 23.09 % (p\ 0.001).
The patients in the risk group were on average 15 years
older than in the non-risk control group (Table 2).
The unadjusted test of the relationship between the
presence of risk factors (coagulopathy, anticoagulant or
antiplatelet therapy) and onset of postoperative secondary
bleeding showed a significant difference of 3.91 versus
1.12 %; p\ 0.001 to the disadvantage of the risk group
(Table 3). The postoperative secondary bleeding rate for
the entire patient collective was 1.42 %. Accordingly, the
rate of complication-related reoperations in the risk group,
at 2.26 %, was significantly higher than in the non-risk
group, at 1.01 % (p\ 0.001). The complication-related
reoperation rate for the entire patient collective was
1.15 %.
Multivariable analysis of postoperative bleeding
in open and endoscopic inguinal hernia repair
The probability of postoperative secondary bleeding was
determined primarily by the surgical technique used
(p\ 0.001) (Table 4). Conduct of an endoscopic operation
resulted in significantly fewer cases of secondary bleeding
(OR = 0.493 [0.431; 0.566]). A higher age increased the
risk of postoperative secondary bleeding (10-year
OR = 1.257 [1.196; 1.321], p\ 0.001). Likewise, coagu-
lopathy, anticoagulant or antiplatelet therapy had a highly
significant impact on the risk of secondary bleeding
(p\ 0.001). The risk of postoperative secondary bleeding
rose in the presence of these risk factors, with an odds ratio
of OR = 2.001 [1.723; 2.323]. With an overall secondary
bleeding rate of 1.4 %, that corresponds to the occurrence
of postoperative secondary bleeding in around 19 out of
1000 patients with existing risk factors (coagulopathy,
anticoagulant or antiplatelet therapy) compared with in 10
out of 1000 patients without that risk profile. Likewise,
there were significantly more cases of secondary bleeding
in the higher ASA categories (p\ 0.001, e.g., ASA III vs.
I: OR = 1.451 [1.187; 1.788]), as well as in male patients
(OR = 1.244 [1.008; 1.536], p = 0.042). Finally, there
was a tendency toward a higher secondary bleeding risk in
the case of larger hernia defects.
Multivariable analysis of reoperations due
to postoperative complications
The rate of complication-related reoperations was, first of
all, negatively impacted by a bilateral operation
(p\ 0.001). Conduct of bilateral repair resulted in signif-
icantly more reoperations (OR = 2.168 [1.826; 2.574])
(Table 5). Likewise, a higher ASA classification (III vs. I:
OR = 1.537 [1.224; 1.929]; IV vs. I: OR = 2.585 [1.365;
4.897]), existing coagulopathy, anticoagulant or antiplate-
let therapy (OR = 1.561 [1.299; 1.874]) and higher age
(10-year OR = 1.112 [1.055; 1.171]) led to a significantly
higher risk of complication-related reoperation
(p\ 0.001). With a total reoperation rate of 1.15 %, this
corresponds to a need for reoperation in around 14 out of
Surg Endosc (2016) 30:2073–2081 2075
123
1000 patients in the risk group, and 9 out of 1000 patients
in the non-risk group.
Conduct of a primary operation (OR = 0.681 [0.562;
0.825]; p\ 0.001, the presence of smaller hernia defects
(p = 0.24; I vs. III: OR = 0.782 [0.623; 0.980]; II vs. III:
OR = 0.825 [0.709; 0.959]) and a endoscopic operation
(p = 0.031; OR = 0.848 [0.730; 0.985]) reduces the
probability of complication-related reoperation.
Multivariable analysis of postoperative bleeding
in endoscopic inguinal hernia repair
There was a highly significant increase in the postoperative
secondary bleeding risk associated with the 47,541 endo-
scopic surgical procedures in the presence of the risk fac-
tors coagulopathy, anticoagulant or antiplatelet therapy
(OR = 2.110 [1.619; 2.749], p\ 0.001) (Table 6). Hence,
Table 1 Demographic and
surgery-related parameters
Coagulopathy, antithrombotic therapy p
Yes No
n % n %
Operation Laparoscopic 4015 44.05 43,526 58.98 \0.001
Open 5100 55.95 30,270 41.02
Sex Male 8319 91.27 65,108 88.23 \0.001
Female 796 8.73 8688 11.77
ASA score I 250 2.74 27,852 37.74 \0.001
II 3911 42.91 38,318 51.92
III 4798 52.64 7470 10.12
IV 156 1.71 156 0.21
Defect size I (\1.5 cm) 967 10.61 12,920 17.51 \0.001
II (1.5–3 cm) 4948 54.28 42,779 57.97
III ([3 cm) 3200 35.11 18,097 24.52
Primary op Yes 8005 87.82 66,012 89.45 \0.001
No 1110 12.18 7784 10.55
Bilateral Yes 1180 12.95 12,223 16.56 \0.001
No 7935 87.05 61,573 83.44
EHS classification Medial 2497 28.13 20,895 28.75 \0.001
Lateral 4392 49.48 36,594 50.34
Femoral 111 1.25 1158 1.59
Combination 1877 21.14 14,043 19.32
Drainage Yes 3375 37.03 17,039 23.09 \0.001
No 5740 62.97 56,757 76.91
Table 2 Mean age and
unadjusted p-value
Coagulopathy, antithrombotic therapy p
Yes No
Age (years) Mean ± SD 71.0 ± 10.6 55.6 ± 16.2 \0.001
Table 3 Postoperative bleeding
and unadjusted p value
Coagulopathy, antithrombotic therapy Total p
Yes No
n % n % n %
Postoperative bleeding No 8759 96.09 72,971 98.88 81,730 98.58 \0.001
Yes 356 3.91 825 1.12 1181 1.42
Reoperation No 8909 97.74 73,050 98.99 81,959 98.85 \0.001
Yes 206 2.26 746 1.01 952 1.15
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Table 4 Multivariable analysis
of postoperative bleeding in
open and laparoscopic inguinal
hernia repair
Parameter p-value Category OR [95 % CI]
Operation \0.001 Laparoscopic versus open 0.493 0.431 0.566
Coagulopathy, antithrombotic therapy \0.001 Yes versus no 2.001 1.723 2.323
Age \0.001 1.257 1.196 1.321
ASA score \0.001 II versus I 0.966 0.815 1.146
III versus I 1.451 1.178 1.788
IV versus I 2.253 1.342 3.785
Primary-OP \0.001 Yes versus no 0.749 0.632 0.888
EHS classification 0.001 Femoral versus combination 1.210 0.711 2.060
Lateral versus combination 1.206 1.027 1.415
Medial versus combination 0.907 0.759 1.085
Bilateral 0.005 Yes versus no 1.317 1.087 1.595
Sex 0.042 Male versus female 1.244 1.008 1.536
Defect size 0.121 I versus III 0.883 0.721 1.083
II versus III 0.871 0.761 0.995
Table 5 Multivariable analysis
of reoperations due to
postoperative complications
Parameter p-value Category OR [95 % CI]
Bilateral \0.001 Yes versus no 2.168 1.826 2.574
ASA score \0.001 II versus I 0.950 0.797 1.132
III versus I 1.537 1.224 1.929
IV versus I 2.585 1.365 4.897
Coagulopathy, antithrombotic therapy \0.001 Yes versus no 1.561 1.299 1.874
Age \0.001 1.112 1.055 1.171
Primary op \0.001 Yes versus no 0.681 0.562 0.825
EHS classification 0.024 Femoral versus combination 1.686 1.032 2.754
Lateral versus combination 1.134 0.952 1.351
Medial versus combination 0.939 0.773 1.140
Defect size 0.024 I versus III 0.782 0.623 0.980
II versus III 0.825 0.709 0.959
Operation 0.031 Laparoscopic versus open 0.848 0.730 0.985
Sex 0.460 Male versus female 0.922 0.743 1.144
Table 6 Multivariable analysis
of postoperative bleeding in
laparoscopic inguinal hernia
repair
Parameter p-value Category OR [95 % CI]
Coagulopathy, antithrombotic therapy \0.001 Yes versus no 2.110 1.619 2.749
Age \0.001 1.192 1.102 1.290
EHS classification \0.001 Femoral versus combination 1.459 0.647 3.293
Lateral versus combination 1.204 0.932 1.555
Medial versus combination 0.690 0.502 0.949
ASA score 0.005 II versus I 0.867 0.673 1.117
III versus I 1.333 0.954 1.863
IV versus I 2.617 0.789 8.685
Primary op 0.012 Yes versus no 0.689 0.515 0.923
Defect size 0.048 I versus III 0.682 0.480 0.967
II versus III 0.787 0.629 0.986
Sex 0.062 Male versus female 1.438 0.982 2.106
Bilateral 0.137 Yes versus no 1.186 0.947 1.484
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that corresponds to 13 cases of secondary bleeding for each
1000 endoscopic inguinal hernia operation in the risk group
compared with six cases of secondary bleeding in patients
without that risk profile, and it applies for an overall sec-
ondary bleeding rate of 0.9 % for endoscopic operations. A
higher age (p\ 0.001) as well as a higher ASA classifi-
cation (p = 0.003) increased the secondary bleeding risk.
The influence of gender as well as of recurrence was only
tendentially reflected for the endoscopic data (p = 0.107
and p = 0.058, respectively), whereas the influence of
hernia defect size was significantly revealed here
(p = 0.015). A small hernia defect reduced secondary
bleeding risk (e.g., I vs. III: OR = 0.646 [0.459; 0.910].
Multivariable analysis of postoperative bleeding
in open inguinal hernia repair
The strongest influence on onset of postoperative sec-
ondary bleeding in the 35,370 open operations was exerted
by higher ASA classification, antithrombotic therapy or
coagulopathy and bilateral operations (p\ 0.001)
(Table 7). Here, too, the presence of coagulopathy, anti-
coagulant or antiplatelet therapy significantly increased the
risk of postoperative secondary bleeding (p\ 0.001), with
an odds ratio OR = 1.879 [1.576; 2.239]. With an overall
secondary bleeding rate of around 2.1 % for open proce-
dures, postoperative secondary bleeding thus occurs in 28
out of 1000 patients with the risk profile and in 13 out of
1000 patients without that profile. Likewise, the secondary
bleeding rate rises in line with higher ASA classification
and bilateral operation (p\ 0.001). Here the influence of
primary operation or recurrence and of gender can only be
tendentially reflected (p = 0.062 and p = 0.113, respec-
tively). The influence exerted by hernia defect size cannot
be identified (p = 0.404).
Discussion
The present analysis investigated the influence exerted by
coagulopathy or antithrombotic therapy on onset of post-
operative secondary bleeding after inguinal hernia surgery.
In doing so, it also identified other influence factors for the
occurrence of secondary bleeding after inguinal hernia
operation. To that effect, 82,911 patients who had under-
gone inguinal hernia operation and whose data were
recorded in the Herniamed Registry were classified as
belonging to either the risk group with existing coagu-
lopathy/receiving antithrombotic therapy (11 %) or to a
non-risk group (89 %), and were then compared with each
other. Comparison revealed a significantly higher postop-
erative secondary bleeding rate of 3.91 % in the risk group
versus a 1.12 % rate in the non-risk group with the total
rate of 1.42 %. Other negative influence factors identified
in multivariable analysis for onset of postoperative sec-
ondary bleeding were conduct of open inguinal hernia
operation, higher patient age, higher ASA score, recur-
rence, male gender and a larger hernia defect. These results
concord with an extent with those of the Swedish Hernia
Registry. In the Swedish Hernia Registry, too, significantly
more postoperative complications occurred in men, in
patients with a higher age as well as in recurrences [8].
However, that study did not investigate the impact of dif-
ferent influence factors on individual postoperative com-
plications. But an important difference between the registry
data is that in the Swedish Hernia Registry more postop-
erative complications occurred after laparoscopic/endo-
scopic inguinal hernia operations than after open
operations. In the Herniamed Registry, fewer cases of
postoperative bleeding occurred after endoscopic proce-
dures (TEP, TAPP) than after open operations. Hence, the
complication-related reoperation rate following endoscopic
inguinal hernia repair (TEP, TAPP) was significantly lower
Table 7 Multivariable analysis
of postoperative bleeding in
open inguinal hernia repair
Parameter p-value Category OR [95 % CI]
Age \0.001 1.301 1.220 1.387
Coagulopathy, antithrombotic therapy \0.001 Yes versus no 1.940 1.619 2.324
ASA score \0.001 II versus I 1.053 0.835 1.328
III versus I 1.543 1.175 2.026
IV versus I 2.252 1.253 4.046
Bilateral 0.001 Yes versus no 1.864 1.283 2.710
Primary op 0.024 Yes versus no 0.785 0.637 0.968
Sex 0.210 Male versus female 1.176 0.913 1.515
EHS classification 0.292 Femoral versus combination 1.064 0.526 2.154
Lateral versus combination 1.178 0.959 1.449
Medial versus combination 1.019 0.818 1.270
Defect size 0.463 I versus III 1.036 0.806 1.331
II versus III 0.920 0.778 1.087
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compared with the open operation. However, data analysis
revealed that in the present study the proportion of
endoscopic/laparoscopic inguinal hernia repairs was
smaller in the risk group with coagulopathy or
antithrombotic therapy (44.5 %) than in the non-risk
group (58.98 %). Therefore, it must be assumed that an
open surgical procedure was indicated more often in the
risk group due to the presence of an elevated risk of
bleeding complication. That means that the differential
therapeutic approach taken in the risk group prior to
surgery with regard to selecting either an open or a
laparoscopic technique differed from that used in the non-
risk group. It can thus be assumed that more patients with
a poor risk profile for secondary bleeding were operated
on using an open technique. That larger hernia defects in
general entail more extensive dissection and accordingly
result in a larger wound area, which helps to explain the
influence exerted by the defect size on the probability of
secondary bleeding. However, it was also noted that
extensive dissection as required for endoscopic inguinal
hernia repair does not necessarily lead to a higher rate of
secondary bleeding and complication-related reoperations
in patients with coagulopathy, anticoagulant or antiplate-
let therapy compared with open surgery.
In summary, it can be noted that in the patient group
undergoing inguinal hernia operation while receiving
antithrombotic therapy or with existing coagulopathy, the
risk for onset of postoperative secondary bleeding is
fourfold higher than in patients without that risk profile.
Other factors related to the individual patient and hernia
type constitute an additional risk constellation for postop-
erative secondary bleeding. For example, a male patient
with a high age, unfavorable ASA score, on antithrombotic
therapy or with existing coagulopathy and a larger hernia
defect or with recurrent hernia has the highest risk for onset
of postoperative secondary bleeding. Accordingly, the
choice of operation technique and of surgeon should be
tailored to that risk profile. Conduct of inguinal hernia
operations for patients on antithrombotic therapy or with
existing coagulopathy requires a high level of attention and
of expertise on the part of the surgeon. In this respect, the
use of an endoscopic technique rather tends to reduce the
risk of secondary bleeding and complication-related reop-
erations. The subtle dissection technique employed for the
endoscopic repair procedure does appear to be associated
with a lower risk of secondary bleeding compared with the
open operation. Accordingly, when using subtle dissection
and hemostasis techniques, endoscopic inguinal hernia
repair can also be recommended for risk patients with
coagulopathy, anticoagulant or antiplatelet therapy, and
other risk factors (bilateral operations, recurrence, higher
age, large hernia defects and male gender).
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